Previous close | 1.1600 |
Open | 1.3485 |
Bid | 1.3100 x 100 |
Ask | 1.3200 x 100 |
Day's range | 1.2600 - 1.7400 |
52-week range | 0.3330 - 19.4700 |
Volume | |
Avg. volume | 1,869,542 |
Market cap | 130.809M |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | -2.9200 |
Earnings date | 05 Aug 2024 - 09 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 1.75 |
FibroGen, Inc. (NASDAQ:FGEN) Q1 2024 Earnings Call Transcript May 6, 2024 FibroGen, Inc. misses on earnings expectations. Reported EPS is $-0.33272 EPS, expectations were $-0.31. FGEN isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and thank you for […]
SAN FRANCISCO, May 07, 2024 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that the company’s management will participate in the following investor conferences: Bank of America Health Care Conference Format: 1x1 investor meetings Date: Tuesday, May 14, 2024 Location: Las Vegas, NV H.C. Wainwright 2nd Annual Bioconnect Investor Conference Format: Fireside Chat and 1x1 investor meetings Date: Monday, May 20, 2024 Fireside Chat Time: 5:00 – 5:30 PM ET Location: New York, NY The l